SOD1 and infarction: In vivo, amifostine increased the SOD activity and reduced MDA level in I/R mice, decreased myocardial infarct size, reduced cell apoptosis and the expression of proapoptotic related proteins, and reduced DHE staining and the expression of SOD related proteins.